Company Filing History:
Years Active: 2009
Title: Berta Iosefzon: Innovator in Pharmaceutical Formulations
Introduction
Berta Iosefzon is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of two patents to her name, Iosefzon's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Iosefzon's latest patents focus on Rasagiline formulations and processes for their preparation. The subject invention provides a pharmaceutical composition comprising N-propargyl-1(R)-aminoindan mesylate, a pharmaceutically acceptable carrier, and a specific concentration of a compound having a defined structure. This innovative formulation aims to enhance the efficacy and safety of Rasagiline, a medication used in the treatment of Parkinson's disease.
Career Highlights
Berta Iosefzon is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. Her role at Teva allows her to leverage her expertise in pharmaceutical formulations and contribute to the development of new therapeutic solutions.
Collaborations
Throughout her career, Iosefzon has collaborated with notable colleagues, including Jeffrey Sterling and David Lerner. These collaborations have fostered a dynamic environment for innovation and have contributed to the advancement of pharmaceutical research.
Conclusion
Berta Iosefzon's work in pharmaceutical formulations exemplifies the impact of innovative thinking in medicine. Her contributions, particularly in the area of Rasagiline formulations, highlight her commitment to improving patient outcomes. Iosefzon's achievements serve as an inspiration for future inventors in the pharmaceutical industry.